Laboratorio LIBRA carries out a Renovation Program of its equipment to be in the front line, with the latest technology in our sphere of action.
The acquisition of new markets, has made Libra enlarge Laboratorio LIBRA enlarge its facilities throughout the years.
Our production plant has the capacity to cover both, the internal and external market.
Our Quality Control holds high technology and different areas to analyze segregated products.Our Quality Control holds high technology and different areas to analyze segregated products.
Analysis capability comprises all imported products, besides our own products.
Laboratorio LIBRA is a Uruguayan company, located in Montevideo, capital of the Republic of Uruguay.
Uruguay, geographical centre of MERCOSUR, has the highest income per capita of the continent and a GDP of 600 trillion dollars. It is a country of 3:300.000 inhabitants and 190.000 sq.mts Having a mild climate,Uruguay is a socially stable country.
In MERCOSUR Uruguay is the best "gateway" to the region which comprises 250 million inhabitants.
Uruguay has a vast and diverse network of physical communications that, together with the competitiveness of its financial services and an infrastructure that supports corporate activity, allows access to the hub of business in MERCOSUR, and its projection towards other regions and countries.
Since its origin as an independent nation, the development of the economic activity in Uruguay has been supported by a perfect symbiosis: an abundance of natural resources and the work of its people - mostly European immigrants -.
A traditionally non-religious, free and compulsory education, has been the backbone for successive generations of Uruguayans in their primary, secondary and tertiary schooling.
The use of this highly-qualified labour force explains the ease of adaptation to new technology in production processes. Uruguayans' superior high qualifications have always been one of the main comparative advantages of the country.
In addition to the above, its political and economic stability, a high health coverage has been developed. The level of training of Uruguayan people, explains the easy adaptation to the use of new technologies in production processes. Historically, the level of training of Uruguayan has been a major comparative advantages of the country. In addition, its long political and economic stability, high health coverage (90% of the population; 1 physician per 275 inhabitants) and its open and cosmopolitan society, have led to its current position as the ideal platform for projecting business towards the region and the world.
Actively promotes a relationship based on exchange and respect with its people. Ongoing training as a permanent process focuses on individual growth, personal motivation and commitment to quality. Particular importance is given to occupational health.
LIBRA’s growth within the pharmaceutical industry means the creation of new work places in a background of job stability.
A large proportion of its company’s staff has more than fifteen years of work at LIBRA.
]]>
Bolivia
LABORATORIOS ABD LTDA.
Km.18 Carretera al norte, Warnes,
Santa Cruz de la Sierra, Bolivia.
Tel.: (591-3) 385.3287
Brasil
LABORATORIOS LIBRA DO BRASIL S.R.L.
Av. Cairu 750, Barrio Navegantes,
Porto Alegre, RS, Brasil.
Tel.: (55-51) 3362.6502
Costa Rica
ONCO FARMA S.A.
25 metros al norte Estacionamiento del Más x Menos, Edificio N°056,
San Pedro de Montes de Oca, San José de Costa Rica, Costa Rica.
Tel.: (506) 2234.4446 / 2281.3678
e-mail: oncofarmacr@racsa.co.cr
Chile
LIBRA CHILE S.A.
Avda. Apoquindo 5555, Oficina 811, Las Condes,
Santiago de Chile, Chile.
Tel.: (562-2) 201.7703
Colombia
LABORATORIOS BIOPAS S.A.
Calle 127ª N°53ª-35, Edificio Colpatria, Torre 2, Oficina 1202,
Bogotá, Colombia.
Tel.: (571) 743.2121
Cuba
MEDICARIBE S.A.
7ma. Avenida 6214, Calle 62 y 66, Miramar,
La Habana, Cuba.
Tel.: (537) 204.5806 / 204.5805
Ecuador
FRESENIUS KABI S.A.
Km.4,5 Vía Durán Tambo, Avenida Semillas S/N,
Guayaquil, Ecuador.
Tel.: (593-4) 281.2583 / 281.2573
El Salvador
GUARDADO S.A. DE C.V.
1ra. Avenida Sur y Pasaje Glorita N°412, Colonia Militar, San Jacinto,
San Salvador, El Salvador.
Tel.: (503) 2500.0400 / 2500.0415
Guatemala
RESCO S.A.
21 Calle 8 – 68, Zona 11, Colonia Mariscal,
Ciudad de Guatemala, Guatemala.
Tel.: (502) 2414.1516 / 2442.1200
Honduras
DROGUERÍA AMERICANA S.A. DE C.V.
Calle Bustamante y Rivero N° 3002, atrás de la Iglesia Medalla Milagrosa, Barrio San Felipe,
Tegucigalpa, Honduras.
Tel.: (504) 280.4444 / 280.4445
Nicaragua
PHARMAINSA – FARMACOS INTERNACIONALES DE NICARAGUA S.A.
Semáforos Guanacaste 200 metros norte y 100 metros este, Reparto Las Palmas,
Managua, Nicaragua.
Tel.: (505) 2266.0323
Panamá
US PHARMACY SYSTEMS INC. – IMEXSATEC S.A.
Avenida Centenario N° 31, Costa del Este,
Ciudad de Panamá, Panamá.
Tel.: (507) 271.6900 / 271.6901
e-mail: info@uspsg.com
Paraguay
LIBRA PARAGUAY S.A.
Prof. Dr. Pedro Ciancio 1443,
Asunción, Paraguay.
Tel.: (595-21) 224.526
República Dominicana
FARACH S.A.
Avenida Charles Summers N° 49, Urbanización Los Prados,
Santo Domingo, República Dominicana.
Tel.: (1-809) 544.0222
Uruguay
LABORATORIO LIBRA S.A.
Arroyo Grande 2832,
Montevideo, Uruguay.
Tel.: (598) 1704
e-mail: info@lablibra.com
Venezuela
LABORATORIO FARMACÉUTICO LIBRA S.A.
Avenida Solano López, Edificio Galerías Bolívar, Oficina 12-A, Sabana Grande,
Caracas DC, Venzuela.
Tel.: (58-212) 631.2664
Located in the very center of Montevideo, Laboratorio LIBRA has a responsible policy regarding the environment. It implements serious solutions for the disposal of waste products and the recycling of various materials.
Through its association with the School of Chemistry of the University of the Republic of Uruguay, it ensures the appropriate destruction of special waste products.
The company contributes with social aimed enterprises through the recycling of materials such as glass, plastic and paper.
REPAPEL is a NGO which develops an environmental education program (the program has the same name), focused on the management (collection and recycling) of paper in public schools and sponsoring organizations. Disposed paper in schools and sponsoring organizations is taken to recycling warehouses and factories and from them, recycled paper materials and items return to participating schools. Besides, different environmental education activities are organized for teachers and students.
RECOPLAST specialized in plastic recycling. It manufactures all kinds of plastic articles with the materials obtained. Young people in the process of rehabilitation participate in this activity with a social aim.
COREVI is a glass recycling coop formed by ex-workers of the Uruguayan Glass factory.
The Association of National Laboratories (ALN) and the Chamber of Pharmaceutical Specialties (CEFA) have developed, jointly with PLATERAN SA (FARMARED-LOGIRED), the PLESEM plan, a plan for the safe elimination of drug containers disposed by their final users. This plan is the first field specific management plan, authorized by the Ministry of Housing, Territorial Management and the Environment, RM 1172/2010, which complies with the requirements of decree No. 260/007 setting forth the disposal of container residues.
This plan establishes that expired drugs containers and drug containers generated at the user’s home must be deposited in the ECOFARMA depositories placed in pharmacies, to look after our health and the health of our loved ones, thus ensuring an environmentally adequate management. This management, to which Laboratorio Libra adheres, takes account our commitment with the community and the environment.
For more information, please visit: www.plesem.com.uy
GMP
LIBRA owns one of the few Uruguayan pharmaceutical plants certified according to the latest GMP (Good Manufacturing Practices) in force of the World Health Organization, and of the demanding Agencia Nacional de Vigilancia Sanitaria (ANVISA) from Brazil. Produces plants approved by different health authorities, Uruguay and Latin America: National Institute for Drug and Food Surveillance (INVIMA Colombia), ANVISA Brazil and the National Drug Administration, Food and Medical Technology (ANMAT Argentina).
Quality Control
Its quality control laboratory is equipped to the highest regional level. It is continually updated and has specialized areas for the analysis of segregated products. It ensures meeting the latest international pharmacopeial specifications.
Exchangeability and clinical studies
LIBRA has a Program for Pharmaceutical Equivalence and Bioequivalence that certifies its products, guaranteeing both doctors and patients that the product indicated is safe and reliable. The research is carried out by Brazilian Organizations approved by ANVISA and the Centro de Biodisponibilidad y Bioequivalencia de Medicamentos (CEBIOBE) from the University of the Republic of Uruguay. Committed to the development of safe and effective products LIBRA invests in clinical studies working in cooperation with the Academia. This is done in a responsible way following the highest standards of ethics.
Pharmacovigilance
Monitors the safety of the products through the Pharmacovigilance Program.
Human Resources
The work is carried out by teams of highly trained personnel, committed to maintaining the company’s quality standards and objectives.
Quality Assurance
Quality Management System comprises:
designing, revision, approval of procedures and its distribution control product release for sale
validation of processes, systems and analytical methods equipment qualification
stability program for all products suppliers qualification nonconformities follow-up recall system
staff training
internal and external audits
health checks of staff
]]>
Any medicine has the potential of triggering adverse events, even those where there is a long process of development, research and manufacturing under strict quality conditions.
Pharmacovigilance is a responsibility shared by doctors, the pharmaceutical industry, health authorities and the patients. Activities encompassed by Pharmacovigilance favor the rational and safe use of medicines oriented to be of advantage to our health.
For that reason, despite the fact there is low probability of adverse events with the use of our medicines, we invite you to contact us if you have any doubt regarding the safety of our products.
The information provided shall be confidential.
Fields marked with * have to be filled to guarantee reception of the message.]]>
Its quality control laboratory is equipped to the highest regional level. It is continually updated and has specialized areas for the analysis of segregated products. It ensures meeting the latest international pharmacopeial specifications.
Exchangeability and clinical studies
LIBRA has a Program for Pharmaceutical Equivalence and Bioequivalence that certifies its products, guaranteeing both doctors and patients that the product indicated is safe and reliable.
The research is carried out by Brazilian Organizations approved by ANVISA and the Centro de Biodisponibilidad y Bioequivalencia de Medicamentos (CEBIOBE) from the University of the Republic of Uruguay.
Committed to the development of safe and effective products LIBRA invests in clinical studies working in cooperation with the Academia. This is done in a responsible way following the highest standards of ethics.
Pharmacovigilance
Monitors the safety of the products through the Pharmacovigilance Program.
Human Resources
The work is carried out by teams of highly trained personnel, committed to maintaining the company’s quality standards and objectives.
Quality Assurance
Quality Management System comprises:
- designing, revision, approval of procedures and its distribution control
- product release for sale
- validation of processes, systems and analytical methods
- equipment qualification
- stability program for all products
- suppliers qualification
- nonconformities follow-up
- recall system
- staff training
- internal and external audits
- health checks of staff